Gregg Stone, M.D., director of cardiovascular research and education at Columbia University Medical Center / New York-Presbyterian Hospital, explains ABSORB Trial data showing bioresorbable stents had poor outcomes in small coronary vessels. This might be included as a restriction in the instructions for use of the Abbott Absorb stent, which is currently pending FDA final review. Read the related article "Questions Remain on Future of Bioresorbable Stents." Also, read the article "FDA Approves First Totally Bioresorbable Stent."
VIDEO: Avoiding Higher Risk Cath Lab Patients May Not Improve Outcomes Scores
Ashwin Nathan M.D., a cardiology fellow in the division of Cardiovascular Medicine at the Hospital of the University of Pennsylvania, presented a late-breaking study at the Society of Cardiovascular Angiography and Interventions (SCAI) 2021 meeting that looked at hospital-level percutaneous coronary intervention (PCI) performance data and simulated if what would happen if hospitals removed their highest risk patients. The findings suggest this risk avoidance strategy does not necessarily mean the hospital will get higher performance scores.
Read more in the article Avoiding High-risk Cath Lab Procedures Does Not Necessarily Improve Hospital Scores.
Dr. Vinod Thourani, M.D., professor of surgery, Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine and a co-investigator for the PARTNER II Trial, discusses the biggest news item from American College of Cardiology (ACC) 2016 meeting — the Sapien 3 TAVR device performed better that surgical aortic valve replacement in a TAVR vs. SAVR comparison for the first time.
Examples of clinical decision support software currently on the market that might be leveraged to address Stage 3 Meaningful Use from the expo floor of HIMSS 2016. Ascendian Healthcare Consulting CEO Shawn McKenzie also discusses how and why CDS should be integrated into the radiology workflow. Read the April 2017 article “CMS to Require Appropriate Use Criteria Documentation for Medical Imaging Orders.”
Don Woodlock, vice president and general manager of cardiology IT for GE Healthcare, highlights four new innovations related to Centricity Cardio Enterprise. Link to GE Healthcare's Interactive, Digital Guide for Centricity Cardio Enterprise
Examples of patient engagement technologies for medical imaging to meet health IT Stage 3 Meaningful Use requirements. Discussion includes examples from the expo floor at HIMSS 2016 and Ascendian Healthcare Consulting CEO Shawn McKenzie explaining ways radiology can leverage technology to engage patients with images, reports and radiation dose records.
Examples of technologies on the market and a discussion of what to look for in radiology PACS and cardiology information systems (CVIS) workflow efficiencies with Ascendian Healthcare Consultant Jef Williams. DAIC Editor Dave Fornell takes viewers on a tour of key workflow improvements offered by health IT vendors at the Health Information Management Systems Society (HIMSS) 2016.
Managing inventory in the procedural area is often a challenge that creates substantial waste and inefficiency that impacts your bottom line. Understanding how to overcome the top barriers allows you to spend more time on patient care and less time on tackling your supplies. Learn how you can manage inventory more effectively with Cardinal Health Inventory Management Solutions. For more information visit cardinalhealth.com/cims.
John Showalter, M.D., CHIO, University of Mississippi Medical Center, explains how he created population health monitoring programs to help identify high-risk patients that should receive extra attention to reduce readmissions.
He said electronic medical record data can be mined for information by smart computer algorithms to identify risk factors beyond clinical vital signs and test results. For example, if a heart failure patient has several doctor visits in his medical record for things that might be related to his heart failure symptoms, but there was failure for patient followup leading to a hospital admission. The algorithm also looks at things like the patient's address and its distance to their pharmacy, their socio-economic level and if they have a car and drive. He said these non-clinical factors outside of the hospital can have major impact on the ability of the patient to maintain medication compliance to help keep them out of the hospital.
Related Heart Failure Content:
ITN/DAIC Editor Dave Fornell shows his choices for some of the most innovative new radiology imaging technologies on the expo floor at Radiological Society of North America (RSNA) 2015 meeting.
Interview with Jon Brubaker, MBA, RCVT, ultrasound technology analyst, MD Buyline, explains the trends and new technology he saw at the Radiological Society of North America (RSNA) 2015 meeting.
Video discussion of new technology and trend highlights at the Radiological Society of North America (RSNA) 2015 meeting with DAIC/ITN editor Dave Fornell and ITN contributing editor Greg Freiherr.
Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and interventional cardiology technology trends at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.
DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies presented on the expo floor and in sessions at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) meeting.
Guillaume Baillaird, CEO of ControlRad Systems, described how his company's technology can significantly reduce radiation dose to staff and patients during angiography procedures.
Ziad Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York-Presbyterian Hospital, explains recent advances in IVUS, OCT and FFR. This was a big topics discussed at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the article “10 Reasons Why You Need Supplemental Imaging in the Cath Lab.”
Sunil Rao, M.D., associate professor of medicine and a member in the Duke University Clinical Research Institute, a leading proponent of radial access offers insights as to where radial access is at in the United States. Radial access is rapidly growing and was a topic of late-breaking trials presented at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the article "Radial Access Adoption in the United States."
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford University Medical Center, explains balloon-based lithoplasty as a new alternative for treating heavily calcified coronary and peripheral vascular disease lesions. The technology was among the new innovations at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.
Intravascular Lithotripsy uses sonic pressure waves, also known as shockwaves, that pass through soft arterial tissue and preferentially disrupt calcified plaque by creating a series of micro-fractures. After the calcium has been cracked, the artery can be expanded at low pressure and a stent safely implanted to improve blood flow, with minimal trauma to normal arterial tissue.
Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of Adelaide in Australia, and co-principal investigator of Medtronic's recently launched international drug-filled stent (DFS) clinical trial, explains DFS the new technology. This was among the top innovations presented at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for both the ABSORB and SYNERGY stent trials, discussed the latest developments in bioresorbable stent technology. Bioresorbable stent technology was among the top innovations presented at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the article "FDA Approves First Totally Bioresorbable Stent."
Manesh Patel, M.D., associate professor of medicine, and director of interventional cardiology and the cath labs at Duke University, explains the innovations in interventional heart failure technologies, including the Aortix percutaneous heart pump. This was among the innovations presented at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read more on this device.
Related Aortix Content
DAIC Editor Dave Fornell shares some of the most innovative new technologies shown on the expo floor and discusses in sessions at the Society of Cardiovascular Computed Tomography (SCCT) 2015 annual meeting.
Interview with James Min, M.D., Professor of Radiology and Medicine and Director of Dalio Institute of Cardiovascular Medicine, Weill Cornell, New York Presbyterian Hospital. Watch the VIDEO “Early U.S. Experience With FFR-CT in Evaluating ED Chest Pain Presentation.” A discussion with Simon Dixon, M.D., MBChB, on the use of fractional flow reserve-computed tomography (FFR-CT) to evaluate chest pain patients in the emergency departmenat Beaumont Hospital in Royal Oak, Mich. Read the article "What is New in FFR Technology."
Interview with Daniel Berman, M.D., FACC, chief of cardiac imaging and nuclear cardiology and professor of imaging, Cedars-Sinai Medical Center, at the Society of Cardiovascular Computed Tomography (SCCT) 2015 meeting.
Watch the VIDEO: The Value of the Cardiovascular Service Line, an interview with Linda Gillam, M.D., Atlantic Health System, who suggests how cardiology-related services can demonstrate their value to providers and patients.
Watch the VIDEO: Role of Cardiac CT in Value-based Medicine — Interview with Leslee Shaw, Ph.D.
Interview with Harold Litt, M.D, Ph.D., chief of cardiovascular imaging section and associate professor of radiology, University of Pennsylvania. He also served as co-principal investigator of the ACRIN-PA study of cardiac CT use in the ED. He also served as co-principal investigator of the ACRIN-PA study of cardiac CT use in the emergency department (ED). Litt spoke in sesveral sessions on how to begin using cardiac CT to evaluate chest pain to quickly rule in or rule out heart attacks.
Related ACRIN-PA Study Content:
VIDEO: CT for Chest Pain Evaluation in The Emergency Department — Interview with Harold Litt, M.D.
VIDEO: ACRIN-PA Trial Showed Benefit of CT in Assessing Chest Pain — Litt explaining the trial
Interview with Dee Dee Wang, M.D., FACC, FASE, advanced structural heart imaging staff cardiologist, Henry Ford Hospital, Detroit, about the use of 3-D printing to aid procedural planning and guidance in complex structural heart cases. Read the article “Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts.” Read the article “The Future of 3-D Printing in Medicine.”
Interview with Ricardo Cury, M.D., FAHA, FSCCT, FACC, president of the Society of Cardiovascular Computed Tomography (SCCT) and chairman of radiology, director of cardiac imaging, Baptist Health of South Florida, Miami. He explains recent key trials, radiation dose and perfusion imaging. For more information on cardiac CT advances, read the article “New Technology Supports CT as Prime Cardiac Imaging Modality.”
Interview at the American Society of Echocardiography (ASE) annual meeting with Federico Asch, M.D., M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University.
DAIC Editor Dave Fornell shares his choices for the most innovative new echocardiography technologies and trends at the 2015 American Society of Echocardiography (ASE) annual meeting.
Interview at the American Society of Echocardiography (ASE) annual meeting with Federico Asch, M.D., M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University. He explains some of the new analytic software advances that offer new ways to assess cardiac function.
Interview at the American Society of Echocardiography (ASE) annual meeting with Federico Asch, M.D., M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University. He explains how ultrasound might have a roll in the future for breaking up clots and targeted delivery of gene and drug therapies.
Interview with Steve Goldstein, M.D., director, noninvasive lab, Medstar Washington Heart Institute, Washington, D.C., on the uses of echo guidance for interventional procedures in the cath lab. He spoke with DAIC Editor Dave Fornell at ASE 2015.
Role of Interventional Echcardiography in Transcatheter Structural Heart Procedures — Rebecca Hahn, M.D., Columbia University Medical Center, is an expert in the new subspecialty of interventional echo and shares her insights at the Cardiovascular Research Foundation's (CRF) Transcatheter Valve Therapies (TVT) conference in Chicago in June.
Interview with Ted Feldman, M.D., FACC, MSCAI, FESC, cardiac cath lab director, Evanston Hospital, North Shore Health System, and principle investigator, Everest II MitraClip U.S. pivotal trial, at the Transcatheter Valve Therapies 2015 meeting. Watch the VIDEO “Advances and Future Directions for Transcatheter Valves.”
Treating Mitral Regurgitation in High Risk PatientsUsing the MitraClip — article by Allen Atchley, M.D.
Interview with Michael Reardon, M.D., professor of cardiothoracic surgery at DeBakey Heart and Vascular Center, and chairman of the patient screening committee, CoreValve U.S. pivotal trial, at the Transcatheter Valve Therapies 2015 meeting.
Interview with Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball Center for Innovation, at the Transcatheter Valve Therapies 2015 meeting. Read the article "Transcatheter Mitral Valve Replacement Devices in Development."
Interview with Charanjit Rihal, M.D., chief of cardiology and professor of medicine, Mayo Clinic, at the Transcatheter Valve Therapies (TVT) 2015 meeting in Chicago. He presented a session on how transcatheter septal occlduers used for ASDs, PFOs and VSDs can be used to seal paravalvular leaks around surgical or transcatheter valve replacements to imporve hemodynamic flow.
Interview with Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball Center for Innovation, at the Transcatheter Valve Therapies 2015 meeting. Read the article "Transcatheter Mitral Valve Replacement Devices in Development," and the article "Advances and Future Directions for Transcatheter Valves."
DAIC/ITN Editor Dave Fornell shows examples of new healthcare IT technology at the 2015 HIMSS meeting that will change the future of healthcare. These include healthcare wearable devices, smart phone apps, virtual training software, population health data, and technology for patient engagement. See more exampled of how consumer healthcare technology is rapidly evolving in the VIDEO: Wearable Health Monitors and Apps at the 2018 Consumer Electronics Show.